Effects of yohimbine on plasma levels of leptin in normal and streptozotocin induced diabetic rats

Acta Medica Iranica

Volumn 44, Issue 2, 2006, Pages 77-82

  Mohammadi Naghadeh, M ^a,b   Homayouni Moghadam, F ^a   Ibrahimi, H ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

2 adrenoceptor; Diabetic rats; Insulin; Leptin; Streptozotocin; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; INSULIN; ISOPHANE INSULIN; LEPTIN; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN TREATMENT; LIPOLYSIS; MALE; MONOTHERAPY; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 34347239704     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994 Dec 1; 372(6505):425-432.
2. Havel PJ, Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen CL, Ahren B. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol. 1998 May; 274(5 Pt 2):R1482-1491.
3. Patel BK, Koenig JI, Kaplan LM, Hooi SC. Increase in plasma leptin and Lep mRNA concentrations by food intake is dependent on insulin. Metabolism. 1998 May; 47(5):603-607.
4. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes. 1996 May; 45(5):699-701.
5. Havel PJ. Leptin production and action: relevance to energy balance in humans. Am J Clin Nutr. 1998 Mar; 67(3):355-356.
6. Ahren B, Mansson S, Gingerich RL, Havel PJ. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. Am J Physiol. 1997 Jul; 273(1 Pt 2):R113-120.
7. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995 Nov; 1(11):1155-1161.
8. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol. 2000 Sep; 143(3):293-311.
9. Wellman PJ. Norepinephrine and the control of food intake. Nutrition. 2000 Oct; 16(10):837-842.
10. Kurose Y, Terashima Y. Histamine regulates food intake through modulating noradrenaline release in the para-ventricular nucleus. Brain Res. 1999 May 15; 828(1-2):115-118.
11. Brown CM, MacKinnon AC, Redfern WS, Williams A, Linton C, Stewart M, Clague RU, Clark R, Spedding M. RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors. Br J Pharmacol. 1995 Sep; 116(2):1737-1744.
12. Currie PJ, Wilson LM. Yohimbine attenuates clonidine-induced feeding and macronutrient selection in genetically obese (ob/ob) mice. Pharmacol Biochem Behav. 1992 Dec; 43(4):1039-1046.
13. Hsu WH. Yohimbine increases plasma insulin concentrations and reverses xylazine-induced hypoinsulinemia in dogs. Am J Vet Res. 1988 Feb; 49(2):242-244.
14. Leibel RL, Hirsch J. Site- and sex-related differences in adrenoreceptor status of human adipose tissue. J Clin Endocrinol Metab. 1987 Jun; 64(6):1205-1210.
15. Leibowitz SF. Hypothalamic paraventricular nucleus: interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neurosci Biobehav Rev. 1988 Summer; 12(2):101-109.
16. Bitar MS, Pilcher CW. Insulin-dependent attenuation in alpha 2-adrenoreceptor-mediated nociception in experimental diabetes. Pharmacol Biochem Behav. 1997 Jan; 56(1):15-20.
17. Ruffolo RR Jr, Nichols AJ, Stadel JM, Hieble JP. Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes. Annu Rev Pharmacol Toxicol. 1993; 33:243-279.
18. Kurose T, Seino Y, Nishi S, Tsuji K, Taminato T, Tsuda K, Imura H. Mechanism of sympathetic neural regulation of insulin, somatostatin, and glucagon secretion. Am J Physiol. 1990 Jan; 258(1 Pt 1):E220-227.
19. Robertson RP, Porte D Jr. Adrenergic modulation of basal insulin secretion in man. Diabetes. 1973 Jan; 22(1):1-8.
20. Robertson RP, Halter JB, Porte D Jr. A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest. 1976 Mar; 57(3):791-795.
21. Lacey RJ, Chan SL, Cable HC, James RF, Perrett CW, Scarpello JH, Morgan NG. Expression of alpha 2- and beta-adrenoceptor subtypes in human islets of Langerhans. J Endocrinol. 1996 Mar; 148(3):531-543.
22. Guillot E, Morand R, Bouloy C, Eon MT, Angel I. Involvement of alpha 2-adrenoceptors in metabolic and hormonal responses to a mixed meal in beagle dogs. Am J Physiol. 1995 Dec; 269(6 Pt 1):E991-995.
23. Natali A, Gastaldelli A, Galvan AQ, Sironi AM, Ciociaro D, Sanna G, Rosenzweig P, Ferrannini E. Effects of acute alpha 2-blockade on insulin action and secretion in humans. Am J Physiol. 1998 Jan; 274(1 Pt 1):E57-64.
24. Kawazu S, Suzuki M, Negishi K, Watanabe T, Ishii J. Studies of midaglizole (DG-5128). A new type of oral hypoglycemic drug in healthy subjects. Diabetes. 1987 Feb; 36(2):216-220.
25. Aarnio P, Lauritsen T, Dela F. Insulin secretion and glucose kinetics during exercise with and without pharmacological alpha(1)- and alpha(2)-receptor blockade. Diabetes. 2001 Aug; 50(8):1834-1843.
26. Callahan MF, Beales M, Oltmans GA. Yohimbine and rauwolscine reduce food intake of genetically obese (obob) and lean mice. Pharmacol Biochem Behav. 1984 Apr; 20(4):591-599.
27. Berlan M, Galitzky J, Tran MA, Montastruc P. Anorectic effect of alpha 2-antagonists in dog: effect of acute and chronic treatment. Pharmacol Biochem Behav. 1991 Jun; 39(2):313-320.
28. Levin BE. Reduced paraventricular nucleus norepinephrine responsiveness in obesity-prone rats. Am J Physiol. 1996 Feb; 270(2 Pt 2):R456-61.
29. Barber M, Kasturi BS, Austin ME, Patel KP, MohanKumar SM, MohanKumar PS. Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res. 2003 Feb 21; 964(1):128-135.
30. Titouamane S, Baudouin C. [Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment]. J Fr Ophtalmol. 2002 Jun; 25(6):568-575. French.